Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
Publication/Presentation Date
10-1-2004
Abstract
In 1991 a multidisciplinary group consisting of surgeons, radiation oncologists, medical oncologists, pathologists, research nurses, and laboratory scientists was organized at the Johns Hopkins Hospital to accelerate progress in understanding the clinical and basic biology of pancreatic carcinoma and to develop research protocols aimed at improving clinical outcomes. This article discusses the studies, data, and conclusions generated to date, in some cases preliminarily, for the clinical trials and algorithms the Johns Hopkins team applied to the postoperative adjuvant management of periampullary pancreatic and nonpancreatic periampullary adenocarcinomas during the interval 1991 to 2003.
Volume
13
Issue
4
First Page
621
Last Page
638
ISSN
1055-3207
Published In/Presented At
Abrams, R. A., & Yeo, C. J. (2004). Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Surgical oncology clinics of North America, 13(4), 621–ix. https://doi.org/10.1016/j.soc.2004.06.004
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
15350938
Department(s)
Administration and Leadership
Document Type
Article